These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
800 related articles for article (PubMed ID: 8242546)
1. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546 [TBL] [Abstract][Full Text] [Related]
2. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma. Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605 [TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. Bacci G; Ferrari S; Bertoni F; Ruggieri P; Picci P; Longhi A; Casadei R; Fabbri N; Forni C; Versari M; Campanacci M J Clin Oncol; 2000 Dec; 18(24):4016-27. PubMed ID: 11118462 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide. Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan. Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities. Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G; J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977 [TBL] [Abstract][Full Text] [Related]
9. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Ferrari S; Mercuri M; Picci P; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Longhi A; Rimondini S; Donati D; Manfrini M; Ruggieri P; Biagini R; Bacci G Tumori; 1999; 85(6):458-64. PubMed ID: 10774566 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808 [TBL] [Abstract][Full Text] [Related]
11. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. Bacci G; Ferrari S; Longhi A; Picci P; Mercuri M; Alvegard TA; Saeter G; Donati D; Manfrini M; Lari S; Briccoli A; Forni C; J Chemother; 2002 Apr; 14(2):198-206. PubMed ID: 12017378 [TBL] [Abstract][Full Text] [Related]
13. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience. Bacci G; Ruggieri P; Bertoni F; Ferrari S; Longhi A; Biagini R; Zavatta M; Versari M; Forni C Oncol Rep; 2000; 7(5):1129-33. PubMed ID: 10948351 [TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]. Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997 [TBL] [Abstract][Full Text] [Related]
17. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute. Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928 [TBL] [Abstract][Full Text] [Related]
18. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan. Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942 [TBL] [Abstract][Full Text] [Related]
19. Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies. Bacci G; Picci P; Ferrari S; Casadei R; Brach Del Prever A; Tienghi A; Mancini A J Chemother; 1993 Aug; 5(4):237-46. PubMed ID: 8229152 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]